The summit will focus on Outsourcing Drug Discovery and Clinical Trials.

This meeting will be one of several one day events that will focus on the drug discovery sector. It will offer attendees the opportunity to minimize time away from the office and travel costs whilst still providing an excellent overview of the sector and an opportunity to network with its key players.

Imperial College London


Agenda Topics:
• Outsourcing Medicinal Chemistry Services
• ADME/Toxicology Services
• Selecting the Right Partner
• Maintaining Quality and Excellence Standards
• Implementing and Managing Outsourced Clinical Trials in Europe and Asia
• Selecting the Right Outsourcing Strategy
• Legal and Regulatory Issues

Confirmed Speakers

Keynote Speaker

Raymond Hill, Former Executive Director, Licensing & External Research Europe, Merck,
Imperial College London

Sharpe & Dohme, Heinrich Klech
Professor of Medicine, CEO and VP, Vienna School of Clinical Research
Gerry Kamstra, Partner, Bird & Bird
Lena Martensson,
Associate Director of Discovery Alliances, AstraZeneca
Katherine Tsaioun, CSO/CEO, Apredica
Roderick Porter, Business Development Director, NiKem Research
Thierry Langer, CEO, Prestwick Chemical inc
Michael Shepard, CSO, Biologics21 Group